Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 273

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Characteristics of Lung Cancers Detected by Computer Tomography Screening in the Randomized NELSON Trial

Open access
Horeweg, Nanda, van der Aalst, Carlijn M., Thunnissen, Erik, Nackaerts, Kristiaan, Weenink, Carla, Groen, Harry J. M., Lammers, Jan-Willem J., Aerts, Joachim G., Scholten, Ernst T., van Rosmalen, Joost, Mali, Willem, Oudkerk, Matthijs, de Koning, Harry J.·2013·American Journal of Respiratory and Critical Care Medicine

Abstract

RATIONALE: The NELSON (Nederlands Leuvens Longkanker Screenings Onderzoek) trial is, with 15,822 participants, the largest European lung cancer computer tomography screening trial. A volumetry-based screening strategy, stringent criteria for a positive screening, and an increasing length of screening interval are particular features of the NELSON trial. OBJECTIVES: To determine the effect of stringent referral criteria and increasing screening interval on the characteristics of screen-detected lung cancers, and to compare this across screening rounds, between sexes, and with other screening trials. METHODS: All NELSON participants with screen-detected lung cancer in the first three rounds were included. Lung cancer stage at diagnosis, histological subtype, and tumor localization were compared between the screening rounds, the sexes, and with other screening trials. MEASUREMENTS AND MAIN RESULTS: In the first three screening rounds, 200 participants were diagnosed with 209 lung cancers. Of these lung cancers, 70.8% were diagnosed at stage I and 8.1% at stage IIIB-IV, and 51.2% were adenocarcinomas. There was no significant difference in cancer stage, histology, or tumor localization across the screening rounds. Women were diagnosed at a significantly more favorable cancer stage than men. Compared with other trials, the screen-detected lung cancers of the NELSON trial were relatively more often diagnosed at stage I and less often at stage IIIB-IV. CONCLUSIONS: Despite stringent criteria for a positive screening, an increasing length of screening interval, and few female participants, the screening strategy of the NELSON trial resulted in a favorable cancer stage distribution at diagnosis, which is essential for the effectiveness of our screening strategy. Clinical trial registered with www.trialregister.nl (ISRCTN63545820).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.201209-1651oc

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 273

Metadata

Authors
Horeweg, N., van der Aalst, C. M., Thunnissen, E., Nackaerts, K., Weenink, C., Groen, H. J. M., Lammers, J.-W. J., Aerts, J. G., Scholten, E. T., van Rosmalen, J., Mali, W., Oudkerk, M., & de Koning, H. J.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2013-04-15
Volume
187
Issue
8
Pages
848-854
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2128980868
Cited by
273
References
29
FWCI
18.27
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Characteristics of Lung Cancers Detected by Computer Tomography Screening in the Randomized NELSON Trial. https://app.cochat.ai/papers/10.1164/rccm.201209-1651oc
The paper
Horeweg, N., van der Aalst, C. M., Thunnissen, E., Nackaerts, K., Weenink, C., Groen, H. J. M., Lammers, J.-W. J., Aerts, J. G., Scholten, E. T., van Rosmalen, J., Mali, W., Oudkerk, M., & de Koning, H. J. (2013). Characteristics of Lung Cancers Detected by Computer Tomography Screening in the Randomized NELSON Trial. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201209-1651oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.